HONG KONG—Sino Medical Sciences Technology Inc., (SHA: 688108), a leading medical device company based in China, has announced that it has received marketing approval in Hong Kong for its SC HONKYTONK coronary balloon dilation catheter. This approval marks a significant expansion of the product’s reach, as it is already registered for use in mainland China, the US, Thailand, Taiwan, India, and Russia.
The SC HONKYTONK catheter is a critical tool in the treatment of coronary artery disease, designed for balloon catheter dilation of narrowed segments or bridging sites within the coronary arteries. This procedure is essential for improving myocardial perfusion, which can significantly enhance the quality of life for patients suffering from various heart conditions.
The approval in Hong Kong is a testament to Sino Medical Sciences’ commitment to innovation and the global expansion of its medical device portfolio. The SC HONKYTONK catheter’s proven efficacy and safety profile have made it a valuable asset in the interventional cardiology space, and this latest approval is expected to further strengthen the company’s presence in the region. – Flcube.com
